Federal Register / Vol. 87, No. 96 / Wednesday, May 18, 2022 / Notices 30235 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Hearing 

and Balance Application Review. 

Date: June 8, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

Name of Committee: Communication 

Disorders Review Committee. 

Date: June 16–17, 2022. 

Time: 10:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Kausik Ray, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Blvd., Rockville, MD 20850, 301– 

402–3587, rayk@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Chemical 

Senses Fellowship Review. 

Date: June 21, 2022. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Eliane Lazar-Wesley, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, 6001 Executive Boulevard, Room 

8339, MSC 9670, Bethesda, MD 20892–8401, 

301–496–8683, el6r@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Voice, 

Speech and Language Fellowship Review. 

Date: June 27, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Boulevard, Room 8351, Bethesda, 

MD 20892, (301) 451–6339, kellya2@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Review of 

NIDCD R25 Applications. 

Date: July 6, 2022. 

Time: 3:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Eliane Lazar-Wesley, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, 6001 Executive Boulevard, Room 

8339, MSC 9670, Bethesda, MD 20892–8401, 

301–496–8683, el6r@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; NIDCD, 

National Human Ear Resource Network 

Review. 

Date: July 14, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Katherine Shim, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, NIH/NIDCD, 6001 

Executive Blvd., Room 8351, Bethesda, MD 

20892, 301–496–8683, katherine.shim@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: May 12, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–10622 Filed 5–17–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Eye 

Council. 

The meeting will be held as a virtual 

meeting on June 17, 2022, and is open 

to the public as indicated below. The 

open session (event) will be videocast 

by NIH with closed captioning at: 

https://videocast.nih.gov/watch=45255. 

To request reasonable accommodations, 

please contact Nathan.Brown2@nih.gov 

at least five days before the event. The 

agenda can be found at: https://

www.nei.nih.gov/about/advisorycommittees/national-advisory-eyecouncil-naec/national-advisory-eyecouncil-naec-meeting-agenda. 

A portion of this meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Eye Council. 

Date: June 17, 2022. 

Open: 10:00 a.m. to 2:00 p.m. 

Agenda: Presentation of the NEI Director’s 

report, discussion of NEI programs, and 

concept clearances. 

Place: National Eye Institute, 6700 

Rockledge Drive, 3400, Bethesda, MD 20892 

(Virtual Meeting). 

Closed: 2:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 6700 

Rockledge Drive, 3400, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kathleen C. Anderson, 

Ph.D., Director, Division of Extramural 

Activities, National Eye Institute, National 

Institutes of Health, 6700B Rockledge Drive, 

Room 3440, Bethesda, MD 20892, (301) 451– 

2020, kanders1@nei.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the contact person listed 

above before the meeting or within 15 days 

after the meeting. The statement should 

include the name, address, telephone number 

and, when applicable, the business or 

professional affiliation of the interested 

person. 


lotter on DSK11XQN23PROD with NOTICES1
30236 Federal Register / Vol. 87, No. 96 / Wednesday, May 18, 2022 / Notices 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nei.nih.gov/about/advisory-committees/ 

national-advisory-eye-council-naec, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: May 4, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–10621 Filed 5–17–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement (U01 

Clinical Trial Required) and NIAID SBIR 

Phase II Clinical Trial Implementation 

Cooperative Agreement (U44 Clinical Trial 

Required). 

Date: June 16, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G76, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Marci Scidmore, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, National Institute of Allergy & 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G76, 

Bethesda, MD 20892, (240) 627–3255, 

marci.scidmore@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS). 

Dated: May 13, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–10667 Filed 5–17–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Advisory 

Allergy and Infectious Diseases Council. 

The meeting will be open to the 

public. The open session will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council. 

Date: June 6, 2022. 

Open: 10:30 a.m. to 11:30 a.m. 

Agenda: Report of Institute Director. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Closed: 11:45 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Acquired Immune Deficiency Syndrome 

Subcommittee. 

Date: June 6, 2022. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291 fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Microbiology and Infectious Diseases 

Subcommittee. 

Date: June 6, 2022. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Immunology and Transplantation 

Subcommittee. 

Date: June 6, 2022. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Matthew J. Fenton, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, fentonm@

niaid.nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1